Jeffrey Owen Phillips

Address:

2530 Ashmore Cir APT 18, Thousand Oaks, CA 91362

Phone:

8052773437

VIN:

WBANE73507CM56447

Make:

BMW

Model:

5 SERIES

Year:

2007

US Patent:

6489346, Dec 3, 2002

Filed:

Jan 11, 2000

Appl. No.:

09/481207

Inventors:

Jeffrey Owen Phillips - Ashland MO

Assignee:

The Curators of the University of Missouri - Columbia MO

International Classification:

C07D40112

US Classification:

514338, 514395, 5462737, 5483071

Abstract:

There is provided a solid pharmaceutical composition in a dosage form that is not enteric-coated, having active ingredients including a non-enteric coated proton pump inhibitor and at least one buffering agent. The proton pump inhibitor is omeprazole, lansoprazole, rabeprazole, esomeprazole, pantoprazole, pariprazole, and leminoprazole, or an enantiomer, isomer, derivative, free base, or salt thereof, in an amount of approximately 5 mg to approximately 300 mg; and the buffering agent is in an amount of approximately 0. 1 mEq to approximately 2. 5 mEq per mg of proton pump inhibitor. The dosage form includes a suspension tablet, a chewable tablet, an effervescent powder, or an effervescent tablet. Also provided is a method for treating an acid-related gastrointestinal disorder in a subject in need thereof by administering to the subject a solid pharmaceutical composition.

US Patent:

6645988, Nov 11, 2003

Filed:

Jul 9, 2001

Appl. No.:

09/901942

Inventors:

Jeffrey O. Phillips - Ashland MO

Assignee:

Curators of the University of Missouri - Columbia MO

International Classification:

A61K 314439

US Classification:

514338, 5462737, 5483071, 514395

Abstract:

The present invention relates to pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors. There is provided a liquid or solid pharmaceutical dosage form that is not enteric coated or delayed released containing a proton pump inhibitor and a Primary Essential Buffer. When the dosage form is placed in a liquid phase the Primary Essential Buffer maintains the pH of the environment at a value greater than the pKa of the proton pump inhibitor for a time sufficient to substantially avoid acid degradation of the proton pump inhibitor in the environment. Also provided is a method for treating acid-related gastrointestinal disorders by administering a solid pharmaceutical dosage form; and a kit for the preparation of a liquid oral pharmaceutical composition.

US Patent:

6663167, Dec 16, 2003

Filed:

May 15, 2001

Appl. No.:

09/855811

Inventors:

Jeffrey O. Phillips - Ashland MO 65010
Eugene Gutwein - Columbia MO 65202

International Classification:

B60P 334

US Classification:

296165, 296159, 296 2611, 2961001, 296 376, 135 8813

Abstract:

A shelter/camper/tent assembly for use in a truck bed. The assembly includes a shell and a floor, each being independently and pivotally coupled to the front of the truck bed. A support structure spans between the sidewalls of the truck and operates to suspend the floor in the truck bed. An opening structure is spaced along and secured to the side of the shell and support structure to support the shell when in the open position. A floor extension is pivotally coupled to the rear edge of the floor allowing for an increase in floor surface area. An attachment mechanism for removably securing the floor to the shell allowing for the two members to pivot about the front of the truck bed in unison. A flexible tent section is secured between the shell and floor through the use of fastening devices.

US Patent:

6699885, Mar 2, 2004

Filed:

Jan 19, 2002

Appl. No.:

10/054350

Inventors:

Jeffrey O. Phillips - Ashland MO

Assignee:

The Curators of the University of Missouri - Columbia MO

International Classification:

A61K 314439

US Classification:

514338, 514395, 424717

Abstract:

Disclosed herein are methods, kits, combinations, and compositions for treating gastric acid disorders employing pharmaceutical compositions comprising a proton pump inhibiting agent (PPI) and a buffering agent in a pharmaceutically acceptable carrier.

US Patent:

6780882, Aug 24, 2004

Filed:

Sep 30, 2002

Appl. No.:

10/260132

Inventors:

Jeffrey O. Phillips - Ashland MO

Assignee:

The Curators of the University of Missouri - Columbia MO

International Classification:

A61K 314439

US Classification:

514338, 424717

Abstract:

There is provided a solid pharmaceutical composition having active ingredients that include at least one non-enteric coated proton pump inhibitor and at least one buffering agent. The proton pump inhibitor, for example, omeprazole, lansoprazole, rabeprazole, esomeprazole, pantoprazole, pariprazole, and leminoprazole, or an enantiomer, isomer, derivative, free base, or salt thereof, is present in an amount of approximately mg to approximately mg; and the buffering agent is present in an amount of approximately mEq to approximately mEq per mg of proton pump inhibitor. The dosage form can be non-enteric coated and can be in the form of a suspension tablet, a chewable tablet, an effervescent powder, or an effervescent tablet. Also provided is a method for treating an acid-related gastrointestinal disorder in a subject in need thereof by administering to the subject a solid pharmaceutical composition of the present invention.

US Patent:

7020505, Mar 28, 2006

Filed:

Jan 7, 1999

Appl. No.:

09/600012

Inventors:

Jeffrey Owen Phillips - Ashland MO, US
Roger Eugene Huckfeldt - Columbia MO, US

Assignee:

Curators of the University of Missouri - Columbia MO

International Classification:

A61B 5/00

US Classification:

600310, 600361

Abstract:

A method and apparatus for predicting the outcome of head injury trauma by monitoring cerebrospinal fluid (CSF) characteristics, preferably my monitoring the pH of CSF. The apparatus includes a catheter with a wall section adapted to permit CSF to flow therein, and a sensor located within the catheter such that the CSF is permitted to flow adjacent the tip of the sensor.

US Patent:

7317937, Jan 8, 2008

Filed:

Dec 21, 2005

Appl. No.:

11/313470

Inventors:

Jeffrey Owen Phillips - Ashland MO, US
Roger Eugene Huckfeldt - Columbia MO, US

Assignee:

Curators of the University of Missouri - Columbia MO

International Classification:

A61B 5/00

US Classification:

600310, 600361

Abstract:

A method and apparatus for predicting the outcome of head injury trauma by monitoring cerebrospinal fluid (CSF) characteristics, preferably by monitoring the pH of CSF. The apparatus includes a catheter with a wall section adapted to permit CSF to flow therein, and a sensor located within the catheter such that the CSF is permitted to flow adjacent the tip of the sensor.

US Patent:

7399772, Jul 15, 2008

Filed:

Aug 15, 2003

Appl. No.:

10/641732

Inventors:

Jeffrey Owen Phillips - Ashland MO, US

Assignee:

Curators of the University of Missouri - Columbia MO

International Classification:

A61K 31/4439
C07D 401/12

US Classification:

514338, 514395, 5462737, 5483071

Abstract:

The present invention relates to pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors. There is provided a liquid or solid pharmaceutical composition consisting of a proton pump inhibitor and at least one buffering agent. Also provided is a pharmaceutical composition further comprising a parietal cell activator, an anti-foaming agent, a flavoring agent and combinations thereof; a method for treating acid-related gastrointestinal disorders by administering a solid pharmaceutical composition; and, a kit for the preparation of a liquid oral pharmaceutical composition. Dosage forms include: liquid, powder, tablet, capsule, effervescent powder, effervescent tablet, pellets, and granules.